Capital International LTD Seagen Inc. Transaction History

Capital International LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $3.96 Million - $4.47 Million	-20,681 Reduced 33.33%	41,370 $8.78 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $11.2 Million - $12.3 Million	-59,478 Reduced 48.94%	62,051 $11.9 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $920,434 - $1.47 Million	7,214 Added 6.31%	121,529 $24.6 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $634,502 - $752,353	5,406 Added 4.96%	114,315 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $3.79 Million - $5.04 Million	27,991 Added 34.59%	108,909 $14.9 Million

Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $72,032 - $118,716	662 Added 0.82%	80,918 $14.3 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $3.39 Million - $4.48 Million	28,367 Added 54.67%	80,256 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $38,493 - $51,532	270 Added 0.52%	51,889 $8.02 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $1.94 Million - $2.31 Million	-13,622 Reduced 20.88%	51,619 $8.77 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $465,755 - $555,472	-3,448 Reduced 5.02%	65,241 $10.3 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $394,378 - $547,214	-2,868 Reduced 4.01%	68,689 $9.54 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $11.8 Million - $15.2 Million	71,557 New	71,557 $12.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.